**Core Concept**
Ketamine is a non-competitive NMDA receptor antagonist that has been used as an anesthetic agent, as well as for its analgesic and antidepressant properties. It works by blocking the action of glutamate at NMDA receptors in the central nervous system, leading to dissociative anesthesia and sedation.

**Why the Correct Answer is Right**
Ketamine has several unique properties that make it useful in clinical settings. It is a rapid-acting anesthetic that can be administered intravenously, and it has been shown to have analgesic effects without significant respiratory depression. Additionally, ketamine has been found to have neuroprotective effects and has been used to treat depression and other psychiatric disorders. The mechanism of action of ketamine involves the inhibition of NMDA receptors, which are critical for synaptic plasticity and learning.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because ketamine does not primarily work by inhibiting GABA receptors. While GABA receptors are involved in the anxiolytic and sedative effects of benzodiazepines, ketamine's mechanism of action is centered around NMDA receptor antagonism.
**Option B:** Incorrect because ketamine is not a direct opioid agonist. While it has analgesic effects, these are not mediated through opioid receptors, but rather through its action on NMDA receptors.
**Option C:** Incorrect because ketamine does not primarily work by inhibiting monoamine oxidase (MAO) enzymes. While MAO inhibitors are used to treat depression, ketamine's antidepressant effects are thought to be mediated through its action on NMDA receptors.

**Clinical Pearl / High-Yield Fact**
Ketamine's unique mechanism of action and rapid onset of action make it a useful anesthetic agent in emergency situations, such as trauma or cardiac arrest. Additionally, its analgesic and antidepressant effects make it a promising treatment for chronic pain and treatment-resistant depression.

**Correct Answer: D.**